aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 24 2023 - 8:00AM
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged
in the discovery and development of first-in-class medicines from
its proprietary tRNA synthetase platform, today announced that Jill
Broadfoot, Chief Financial Officer, will present a corporate
overview at the H.C. Wainwright 25th Annual Global Investment
Conference, which is scheduled to take place September 11 – 13,
2023, in New York, NY.
Details of the presentation appear below:
Conference: H.C. Wainwright 25th Annual Global
Investment ConferenceDate: Wednesday, September 13, 2023 Time:
9:30am EDTLocation: New York, NY
In addition to the presentation, company
management will be available to participate in one-on-one meetings
with investors who are registered attendees of the conference. A
webcast of the event will be available on the Investor’s section of
the company’s website at www.atyrpharma.com. Following the event, a
replay of the presentation will be available on the aTyr website
for at least 90 days.
About aTyr
aTyr is a biotherapeutics company engaged in the
discovery and development of first-in-class medicines from its
proprietary tRNA synthetase platform. aTyr’s research and
development efforts are concentrated on a newly discovered area of
biology, the extracellular functionality and signaling pathways of
tRNA synthetases. aTyr has built a global intellectual property
estate directed to a potential pipeline of protein compositions
derived from 20 tRNA synthetase genes and their extracellular
targets. aTyr’s primary focus is efzofitimod, a clinical-stage
product candidate which binds to the neuropilin-2 receptor and is
designed to downregulate immune engagement in fibrotic lung
disease. For more information, please visit www.atyrpharma.com.
Contact:Ashlee DunstonDirector,
Investor Relations and Public Affairsadunston@atyrpharma.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2024 to May 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From May 2023 to May 2024